The Effect of Methylprednisolone on Disease Progression in Relapsing Remitting Multiple Sclerosis: six year-follow up results.

D. İ. GÜNAL, M. GÜLERYÜZ, E. KARAGÖZ, N. BEKİROĞLU, S. AKTAN

Issue: 1999, Volume 5 - Issue 1
0 859

Multiple Sclerosis and Fatigue

Nur YÜCEYAR, Ayşe SAĞDUYU

Issue: 1999, Volume 5 - Issue 1
0 831

Clinical Scales for Multiple Sclerosis

Kadriye ARMUTLU, Rana KARABUDAK

Issue: 1997, Volume 3 - Issue 3-4
0 1012

HLA Tissue Antigens in Multiple Sclerosis

Yaşar ZORLU, Fadime GÜVEN, Serdar KESKEN, Füsun KARAASLAN, Halis GÜGÜL

Issue: 1996, Volume 2 - Issue 3-4
0 912

Serum Vitamin B12 and Folate Levels in Multiple Sclerosis

H. Özden ŞENER, Serpil DEMİRCİ, Nermin MUTLUER

Issue: 1996, Volume 2 - Issue 3-4
0 1284

Effect of lntravenous Methylprednisolone (IVMP) on Clinical and Neurophysiological Parameters in Multiple Sclerosis.

Yaşar KÜTÜKÇÜ, Zeki GÖKÇİL, Zeki ODABAŞI, Okay VURAL, Muzaffer YARDIM

Issue: 1996, Volume 2 - Issue 1-2
0 847

THE ROLE OF CYTOKINES IN MULTIPLE SCLEROSIS

Ayşe ALTINTAŞ, Orhun KANTARCI, Aksel SİVA

Issue: 1995, Volume 1 - Issue 4
0 824

Multiple Sclerosis Cases with Atypical Signs

Türe TUNÇBAY, Dilek EVYAPAN, Neşe ÇELEBİSOY

Issue: 1995, Volume 1 - Issue 2
0 1021

Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population

Gizem Yağmur Yalçın, Cansu Polat Dunya, Zeliha Tülek, Murat Kürtüncü, Mefkure Eraksoy

DOI: 10.4274/tnd.2021.63444

Issue: 2021, Volume 27 - Supplement 1
0 1395

The lmmunopathogenesis of Multiple Sclerosis

Nihal Işık

Issue: 2009, Volume 15 - Supplement 3
0 1039

Magnetic Resonance Imaging in the Diagnosis of Multiple Sclerosis

Rana KARABUDAK

Issue: 2009, Volume 15 - Supplement 3
0 1138

Multiple Sclerosis Patients with Treatment Failure: Agressive Disease, Switching Treatment, Combination Therapies

Muhteşem GEDİZOĞLU

Issue: 2009, Volume 15 - Supplement 3
0 972

Clinical and Radiological Features of Multiple Sclerosis: Three Case Reports

Murat TERZİ

Issue: 2009, Volume 15 - Supplement 3
0 1306

Assesment of quality of life in neurological diseases

Sibel Karşıdağ, Yasemin Ekmekyapar Fırat, Fettah Eren, Sibel Canbaz Kabay, Murat Terzi

DOI: 10.4274/tnd.2023.56649

Issue: 2024, Volume 30 - Issue 1
5743 2773

The influence of self-care agency on quality of life in patients with multiple sclerosis

Ahsen Taştan Gürkan, Afitap Özdelikara

DOI: 10.55697/tnd.2024.9

Issue: 2024, Volume 30 - Issue 3
3213 1915

Determination of important predictors for the fifth-year Expanded Disability Status Scale scores of patients with multiple sclerosis using machine learning

İlknur Buçan Kırkbir, Burçin Kurt, Cavit Boz, Murat Terzi

DOI: 10.55697/tnd.2024.107

Issue: 2024, Volume 30 - Issue 3
2526 1216

Could pulsed radiofrequency stimulation of the proximal greater occipital nerve be a treatment option for refractory chronic migraine patients?

Derya Yavuz Demiray, Ferhat Ege

DOI: 10.55697/tnd.2024.1

Issue: 2024, Volume 30 - Issue 4
3333 1769

The relationship between lesion volume, oligoclonal bands, and cerebrospinal fluid/serum albumin ratio in multiple sclerosis

Güllü Tarhan, Burçe Akbağra Kaya, Arif Musab Akıner, Yaren Betül Yılmaz, Saime Füsun Domaç

DOI: 10.55697/tnd.2024.88

Issue: 2024, Volume 30 - Issue 4
1731 2607

Picture of multiple sclerosis studies in nursing: A bibliometric study

Esra Uslu, Nazmiye Yıldırım

DOI: 10.55697/tnd.2024.15

Issue: 2024, Volume 30 - Issue 4
2141 1664

The effect of demographic features and environmental risk factors on the clinical course in patients with multiple sclerosis

İrem İlgezdi Kaya, Bedile İrem Tiftikçioğlu, Yaşar Zorlu, Levent Öcek, Ufuk Şener, Figen Tokuçoğlu

DOI: 10.55697/tnd.2025.211

Issue: 2025, Volume 31 - Issue 2
1682 1271